Colivelin
| RP20167 | |
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| RP20167 | |
|
|
|
|
|
|
| Ask us a question | |
Colivelin is a hybrid peptide synthesized to enhance the neuroprotective effects of humanin (HN). Colivelin is constructed as activity-dependent neurotrophic factor (ADNF) C-terminally fused to AGA-(C8R) HNG17, which is a potent HN derivative. Cell death induced by overexpressed familial Alzheimer's disease (FAD)-causative genes and beta-amyloid (1-43) can be completely suppressed by colivelin. Colivelin administered intraperitoneally suppresses memory impairment and may serve as a novel drug candidate to treat Alzheimer's disease. |
Colivelin
| Sequence |
{Ser}{Ala}{Leu}{Leu}{Arg}{Ser}{Ile}{Pro}{Ala}{Pro}{Ala}{Gly} {Ala}{Ser}{Arg}{Leu}{Leu}{Leu}{Leu}{Thr}{Gly}{Glu}{Ile}{Asp} {Leu}{Pro} |
| Sequence Shortening | SALLRSIPAPAGASRLLLLTGEIDLP |
| Molecular Formula | C119H206N32O35 |
| Molecular Weight | 2645.1 |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |